Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function
- PMID: 16879488
- DOI: 10.1111/j.1474-8673.2006.00368.x
Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function
Abstract
1 Muscarinic M1-M5 receptors mediate the metabotropic actions of acetylcholine in the nervous system. A growing body of data indicate they also mediate autocrine functions of the molecule. The availability of novel and selective muscarinic agonists and antagonists, as well as in vivo gene disruption techniques, has clarified the roles of muscarinic receptors in mediating both functions of acetylcholine. 2 Selective M1 agonists or mixed M1 agonists/M2 antagonists may provide an approach to the treatment of cognitive disorders, while M3 antagonism, or mixed M2/M3 antagonists, are approved for the treatment of contractility disorders including overactive bladder and chronic obstructive pulmonary disease. Preclinical data suggest that selective agonism of the M4 receptor will provide novel anti-nociceptive agents, while therapeutics-based upon agonism or antagonism of the muscarinic M5 receptor have yet to be reported. 3 The autocrine functions of muscarinic receptors broadly fall into two areas - control of cell growth or proliferation and mediation of the release of chemical mediators from epithelial cells, ultimately causing muscle relaxation. The former particularly are involved in embryological development, oncogenesis, keratinocyte function and immune responsiveness. The latter regulate contractility of smooth muscle in the vasculature, airways and urinary bladder. 4 Most attention has focused on muscarinic M1 or M3 receptors which mediate lymphocyte immunoresponsiveness, cell migration and release of smooth muscle relaxant factors. Muscarinic M4 receptors are implicated in the regulation of keratinocyte adhesion and M2 receptors in stem cell proliferation and development. Little data are available concerning the M5 receptor, partly due to the difficulties in defining the subtype pharmacologically. 5 The autocrine functions of acetylcholine, like those in the nervous system, involve activation of several muscarinic receptor subtypes. Consequently, the role of these subtypes in autocrine, as well neuronal cholinergic systems, significantly expands their importance in physiology and pathophysiology.
Similar articles
-
Muscarinic receptor subtypes in the alimentary tract.J Physiol Pharmacol. 2009 Mar;60(1):3-21. J Physiol Pharmacol. 2009. PMID: 19439804 Review.
-
Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum.J Neurophysiol. 2005 May;93(5):2841-8. doi: 10.1152/jn.00986.2004. Epub 2004 Dec 1. J Neurophysiol. 2005. PMID: 15574798
-
Muscarinic acetylcholine receptors as CNS drug targets.Pharmacol Ther. 2008 Feb;117(2):232-43. doi: 10.1016/j.pharmthera.2007.09.009. Epub 2007 Dec 20. Pharmacol Ther. 2008. PMID: 18082893 Review.
-
Overview of muscarinic receptor subtypes.Handb Exp Pharmacol. 2012;(208):3-28. doi: 10.1007/978-3-642-23274-9_1. Handb Exp Pharmacol. 2012. PMID: 22222692 Review.
-
Muscarinic agonists and antagonists: effects on the urinary bladder.Handb Exp Pharmacol. 2012;(208):375-400. doi: 10.1007/978-3-642-23274-9_16. Handb Exp Pharmacol. 2012. PMID: 22222707 Review.
Cited by
-
Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects.Mediators Inflamm. 2012;2012:409580. doi: 10.1155/2012/409580. Epub 2012 Nov 24. Mediators Inflamm. 2012. PMID: 23226927 Free PMC article. Review.
-
Acetylcholinesterase Inhibitors and Drugs Acting on Muscarinic Receptors- Potential Crosstalk of Cholinergic Mechanisms During Pharmacological Treatment.Curr Neuropharmacol. 2017;15(4):637-653. doi: 10.2174/1570159X14666160607212615. Curr Neuropharmacol. 2017. PMID: 27281175 Free PMC article. Review.
-
Chronic acetylcholinesterase inhibition reduces the effects of physical training on ventricular contractility and coronary bed reactivity in hypertensive rats.Sci Rep. 2024 Sep 13;14(1):21434. doi: 10.1038/s41598-024-69387-3. Sci Rep. 2024. PMID: 39271709 Free PMC article.
-
Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M1 - M5 muscarinic acetylcholine receptors.Bioorg Med Chem Lett. 2019 Feb 1;29(3):471-476. doi: 10.1016/j.bmcl.2018.12.022. Epub 2018 Dec 11. Bioorg Med Chem Lett. 2019. PMID: 30554957 Free PMC article.
-
Depolarizing Effects of Daikenchuto on Interstitial Cells of Cajal from Mouse Small Intestine.Pharmacogn Mag. 2017 Jan-Mar;13(49):141-147. doi: 10.4103/0973-1296.196312. Pharmacogn Mag. 2017. PMID: 28216898 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases